Ghost Tree Capital »

Macrogenics shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Macrogenics (MGNX) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Macrogenics

Tip: Access up to 7 years of quarterly data

All positions including Macrogenics held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Macrogenics by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $638k 150k 4.25

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Macrogenics

Bellevue Group
Armistice Capital
BlackRock
BlackRock
Vanguard Group
Frazier Life Sciences Management
Daniel D. Thurber
State Street Corporation
Geode Capital Management
T. Rowe Price Associates
Two Sigma Investments
Two Sigma Advisers
Acadian Asset Management
Rock Springs Capital Management
Dimensional Fund Advisors

View all funds holding Macrogenics